HEALIUS LIMITED — Director's Dealing 2016

Dec 1, 2016

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Introduced 30/09/01 Amended 01/01/11
Name of entity	PRIMARY HEALTH CARE LIMITED
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Gordon Richard Davis
Date of last notice	3 August 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interestNature of indirect interest(including registered holder)Note: Provide details of the circumstances givingrise to the relevant interest.Date of changeNo. of securities held prior tochangeClassNumber acquiredNumber disposedValue/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuationNo. of securities held afterchange	IndirectAs shown30 November 201615,000 ordinary sharesGR & G DavisSuperannuation FundFully paid ordinary shares15,000Not applicableAverage price of $3.741 per share30,000 ordinary shares

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change

Example: on-market trade, off-market trade, On-market trade exercise of options, issue of securities under dividend reinvestment plan, participation in buyback

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Were the interests in the securities or contracts Not applicable detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the Not applicable trade to proceed during this period? If prior written clearance was provided, on what date Not applicable was this provided?

Charles Tilley Group Company Secretary 2 December 2016

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011